DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $427,000 | +1.9% | 1,653 | +0.2% | 0.05% | +2.0% |
| Q2 2022 | $419,000 | -23.3% | 1,650 | -11.3% | 0.05% | -12.1% |
| Q1 2022 | $546,000 | +1.5% | 1,861 | +13.8% | 0.06% | +7.4% |
| Q4 2021 | $538,000 | +6.1% | 1,635 | -1.8% | 0.05% | -3.6% |
| Q3 2021 | $507,000 | +0.2% | 1,665 | -11.7% | 0.06% | +1.8% |
| Q2 2021 | $506,000 | -23.0% | 1,885 | -35.4% | 0.06% | -24.7% |
| Q1 2021 | $657,000 | -13.4% | 2,920 | -14.6% | 0.07% | -18.0% |
| Q4 2020 | $759,000 | +3.1% | 3,420 | 0.0% | 0.09% | -11.9% |
| Q3 2020 | $736,000 | +21.7% | 3,420 | 0.0% | 0.10% | +13.5% |
| Q2 2020 | $605,000 | +27.6% | 3,420 | -0.2% | 0.09% | +7.2% |
| Q1 2020 | $474,000 | -9.9% | 3,426 | 0.0% | 0.08% | +15.3% |
| Q4 2019 | $526,000 | +0.6% | 3,426 | -5.5% | 0.07% | -6.5% |
| Q3 2019 | $523,000 | +1.0% | 3,626 | 0.0% | 0.08% | -2.5% |
| Q2 2019 | $518,000 | +8.4% | 3,626 | 0.0% | 0.08% | +6.8% |
| Q1 2019 | $478,000 | +24.5% | 3,626 | -2.6% | 0.07% | +10.4% |
| Q4 2018 | $384,000 | -22.3% | 3,721 | -18.1% | 0.07% | -8.2% |
| Q3 2018 | $494,000 | +5.3% | 4,546 | -4.3% | 0.07% | 0.0% |
| Q2 2018 | $469,000 | +6.8% | 4,751 | +9.4% | 0.07% | -14.1% |
| Q2 2016 | $439,000 | +7.9% | 4,342 | +1.1% | 0.08% | +4.9% |
| Q1 2016 | $407,000 | +10.0% | 4,294 | +7.9% | 0.08% | +8.0% |
| Q4 2015 | $370,000 | -9.8% | 3,979 | -17.3% | 0.08% | -15.7% |
| Q3 2015 | $410,000 | -17.7% | 4,810 | -17.2% | 0.09% | -16.8% |
| Q2 2015 | $498,000 | 0.0% | 5,810 | -0.8% | 0.11% | +4.9% |
| Q1 2015 | $498,000 | -13.4% | 5,858 | -12.7% | 0.10% | -3.8% |
| Q4 2014 | $575,000 | -8.9% | 6,710 | -19.2% | 0.11% | -16.5% |
| Q3 2014 | $631,000 | -63.2% | 8,308 | -61.8% | 0.13% | -62.5% |
| Q2 2014 | $1,714,000 | +44.2% | 21,771 | +37.2% | 0.34% | +46.1% |
| Q1 2014 | $1,189,000 | -0.4% | 15,863 | +2.5% | 0.23% | +2.7% |
| Q4 2013 | $1,194,000 | +30.5% | 15,472 | +17.3% | 0.23% | -0.9% |
| Q3 2013 | $915,000 | +37.2% | 13,189 | +25.1% | 0.23% | +37.3% |
| Q2 2013 | $667,000 | – | 10,542 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |